Latest news
Biosimilar therapy shows similar 6-month remission rates in AAV - ANCA Vasculitis NewsANCA Vasculitis News · Wed, 05 Aug 2026 19:11:57 GMTDr Reddy’s gets US FDA approval for cancer biosimilar Rituximab, enters US market - financialexpress.comfinancialexpress.com · Mon, 03 Aug 2026 05:01:58 GMTDr. Reddy's Laboratories Receives US FDA Approval For Rituximab Biosimilar - SahiSahi · Mon, 03 Aug 2026 01:19:52 GMTDr Reddy’s Secures USFDA Approval for Rituximab Biosimilar After Hyderabad Facility Inspection - Geographic Revenue Trends - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 08:06:38 GMTDr Reddy's Receives USFDA Approval for Rituximab Biosimilar After Hyderabad Facility Inspection - Share Repurchase Impact - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 07:57:02 GMTDr Reddy’s wins FDA nod for rituximab biosimilar - ET PharmaET Pharma · Sat, 01 Aug 2026 14:51:11 GMTDr Reddy’s gets USFDA nod for Rituximab biosimilar - The Times of IndiaThe Times of India · Sat, 01 Aug 2026 14:05:00 GMTDr. Reddy's Laboratories wins U.S. FDA approval for rituximab biosimilar - scanx.tradescanx.trade · Fri, 31 Jul 2026 07:00:00 GMT